Everest Medicines Limited (HKG:1952)
Hong Kong · Delayed Price · Currency is HKD 55.75
+0.80 (1.46%)
Sep 29, 2025, 4:08 PM HKT
Everest Medicines Market Cap
Everest Medicines has a market cap or net worth of 19.41 billion as of September 29, 2025. Its market cap has increased by 175.57% in one year.
Market Cap
19.41B
Enterprise Value
18.48B
Revenue
932.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
55.75
Market Cap Chart
Since October 9, 2020, Everest Medicines's market cap has decreased from 20.64B to 19.41B, a decrease of -5.95%. That is a compound annual growth rate of -1.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 19.41B | 24.49% |
| Dec 31, 2024 | 15.59B | 132.87% |
| Dec 29, 2023 | 6.70B | 24.60% |
| Dec 30, 2022 | 5.37B | -47.96% |
| Dec 31, 2021 | 10.33B | -47.98% |
| Dec 31, 2020 | 19.85B | -3.81% |
| Oct 9, 2020 | 20.64B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 281.56B |
| JD Health International | 215.78B |
| Hansoh Pharmaceutical Group Company | 210.92B |
| Innovent Biologics | 159.71B |
| WuXi Biologics | 158.73B |
| Sino Biopharmaceutical | 143.26B |
| Akeso | 125.00B |
| Sichuan Kelun-Biotech Biopharmaceutical | 113.38B |